Alnylam Pharmaceuticals (NASDAQ:ALNY) – Alnylam Shares In Detail…
Alnylam Pharmaceuticals Inc ALNY announced positive results from the Phase 3 APOLLO-B study of patisiran in transthyretin-mediated (ATTR) amyloidosis with cardiomyopathy. The company previously